Correlation between preoperative serum alpha-fetoprotein levels and survival with respect to the surgical treatment of hepatocellular carcinoma at a tertiary care hospital in Veracruz, Mexico
Introduction: Preoperative serum alpha-fetoprotein levels can have predictive value for hepatocellular carcinoma survival. Aim: Our aim was to analyze the correlation between preoperative serum alpha-fetoprotein levels and survival, following the surgical treatment of hepatocellular carcinoma. Metho...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-10-01
|
Series: | Revista de Gastroenterología de México (English Edition) |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2255534X17300919 |
id |
doaj-06c6125a03fe4cc68aff68301a36a63f |
---|---|
record_format |
Article |
spelling |
doaj-06c6125a03fe4cc68aff68301a36a63f2020-11-24T21:57:49ZengElsevierRevista de Gastroenterología de México (English Edition)2255-534X2017-10-01824357360Correlation between preoperative serum alpha-fetoprotein levels and survival with respect to the surgical treatment of hepatocellular carcinoma at a tertiary care hospital in Veracruz, MexicoG. Martínez-Mier0S. Esquivel-Torres1A. Nava-Lacorte2F.A. Lajud-Barquín3S. Zilli-Hernández4L.M. Vázquez-Ramírez5Departamento de Trasplantes de Órganos, Unidad Médica de Alta Especialidad (UMAE) 189 Adolfo Ruiz Cortines, Instituto Mexicano del Seguro Social, Veracruz, Mexico; Corresponding author. Corporativo San Gabriel, Calle Alacio Pérez 918-314, Colonia Ignacio Zaragoza, C.P. 91910, Veracruz, Ver., Mexico. Tel.: +(229) 9327782; Fax: +(229) 9232990.Departamento de Cirugía Oncológica, Unidad Médica de Alta Especialidad (UMAE) 189 Adolfo Ruiz Cortines, Instituto Mexicano del Seguro Social, Veracruz, MexicoDepartamento de Cirugía Oncológica, Unidad Médica de Alta Especialidad (UMAE) 189 Adolfo Ruiz Cortines, Instituto Mexicano del Seguro Social, Veracruz, MexicoDepartamento de Investigación, Unidad Médica de Alta Especialidad (UMAE) 189 Adolfo Ruiz Cortines, Instituto Mexicano del Seguro Social, Veracruz, MexicoDepartamento de Investigación, Unidad Médica de Alta Especialidad (UMAE) 189 Adolfo Ruiz Cortines, Instituto Mexicano del Seguro Social, Veracruz, MexicoDepartamento de Investigación, Unidad Médica de Alta Especialidad (UMAE) 189 Adolfo Ruiz Cortines, Instituto Mexicano del Seguro Social, Veracruz, MexicoIntroduction: Preoperative serum alpha-fetoprotein levels can have predictive value for hepatocellular carcinoma survival. Aim: Our aim was to analyze the correlation between preoperative serum alpha-fetoprotein levels and survival, following the surgical treatment of hepatocellular carcinoma. Methods: Nineteen patients were prospectively followed (07/2005-01/2016). An ROC curve was created to determine the sensitivity and specificity of alpha-fetoprotein in relation to survival (Kaplan-Meier). Results: Of the 19 patients evaluated, 57.9% were men. The mean patient age was 68.1 ± 8.5 years and survival at 1, 3, and 5 years was 89.4, 55.9, and 55.9%. The alpha-fetoprotein cutoff point was 15.1 ng/ml (sensitivity 100%, specificity 99.23%). Preoperative alpha-fetoprotein levels below 15.1, 200, 400, and 463 ng/ml correlated with better 1 and 5-year survival rates than levels above 15.1, 200, 400, and 463 ng/ml (P<.05). Conclusions: Elevated preoperative serum alpha-fetoprotein levels have predictive value for hepatocellular carcinoma survival. Resumen: Introducción: Los niveles séricos de alfafetoproteína (AFP) preoperatoria pueden tener valor predictivo para la sobrevida del hepatocarcinoma (HCC). Objetivo: Analizar la correlación entre los niveles séricos de AFP preoperatoria y la sobrevida posterior al tratamiento quirúrgico del HCC. Métodos: Diecinueve pacientes fueron seguidos prospectivamente (julio del 2005-enero del 2016). Se realizó una curva ROC para determinar la sensibilidad y la especificidad de la AFP con relación con la sobrevida (Kaplan-Meier). Resultados: Se evaluó a 19 pacientes, 57.9% hombres, edad media 68.1 ± 8.5 años con sobrevida a 1, 3 y 5 años del 89.4, el 55.9 y el 55.9%. El punto de corte de AFP fue 15.1 ng/ml (sensibilidad 100%, especificidad 99.23%). Los niveles preoperatorios de AFP menores de 15.1, 200, 400 y 463 ng/ml correlacionaron con mejor sobrevida a 1 y 5 años que niveles mayores de AFP (p < 0.05). Conclusiones: Los niveles séricos preoperatorios elevados de AFP tienen valor predictivo en relación con la sobrevida de HCC. Keywords: Hepatocellular carcinoma, Liver resection, Alpha-fetoprotein, Survival, Palabras clave: Hepatocarcinoma, Resección hepática, Alfafetoproteína, Sobrevidahttp://www.sciencedirect.com/science/article/pii/S2255534X17300919 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
G. Martínez-Mier S. Esquivel-Torres A. Nava-Lacorte F.A. Lajud-Barquín S. Zilli-Hernández L.M. Vázquez-Ramírez |
spellingShingle |
G. Martínez-Mier S. Esquivel-Torres A. Nava-Lacorte F.A. Lajud-Barquín S. Zilli-Hernández L.M. Vázquez-Ramírez Correlation between preoperative serum alpha-fetoprotein levels and survival with respect to the surgical treatment of hepatocellular carcinoma at a tertiary care hospital in Veracruz, Mexico Revista de Gastroenterología de México (English Edition) |
author_facet |
G. Martínez-Mier S. Esquivel-Torres A. Nava-Lacorte F.A. Lajud-Barquín S. Zilli-Hernández L.M. Vázquez-Ramírez |
author_sort |
G. Martínez-Mier |
title |
Correlation between preoperative serum alpha-fetoprotein levels and survival with respect to the surgical treatment of hepatocellular carcinoma at a tertiary care hospital in Veracruz, Mexico |
title_short |
Correlation between preoperative serum alpha-fetoprotein levels and survival with respect to the surgical treatment of hepatocellular carcinoma at a tertiary care hospital in Veracruz, Mexico |
title_full |
Correlation between preoperative serum alpha-fetoprotein levels and survival with respect to the surgical treatment of hepatocellular carcinoma at a tertiary care hospital in Veracruz, Mexico |
title_fullStr |
Correlation between preoperative serum alpha-fetoprotein levels and survival with respect to the surgical treatment of hepatocellular carcinoma at a tertiary care hospital in Veracruz, Mexico |
title_full_unstemmed |
Correlation between preoperative serum alpha-fetoprotein levels and survival with respect to the surgical treatment of hepatocellular carcinoma at a tertiary care hospital in Veracruz, Mexico |
title_sort |
correlation between preoperative serum alpha-fetoprotein levels and survival with respect to the surgical treatment of hepatocellular carcinoma at a tertiary care hospital in veracruz, mexico |
publisher |
Elsevier |
series |
Revista de Gastroenterología de México (English Edition) |
issn |
2255-534X |
publishDate |
2017-10-01 |
description |
Introduction: Preoperative serum alpha-fetoprotein levels can have predictive value for hepatocellular carcinoma survival. Aim: Our aim was to analyze the correlation between preoperative serum alpha-fetoprotein levels and survival, following the surgical treatment of hepatocellular carcinoma. Methods: Nineteen patients were prospectively followed (07/2005-01/2016). An ROC curve was created to determine the sensitivity and specificity of alpha-fetoprotein in relation to survival (Kaplan-Meier). Results: Of the 19 patients evaluated, 57.9% were men. The mean patient age was 68.1 ± 8.5 years and survival at 1, 3, and 5 years was 89.4, 55.9, and 55.9%. The alpha-fetoprotein cutoff point was 15.1 ng/ml (sensitivity 100%, specificity 99.23%). Preoperative alpha-fetoprotein levels below 15.1, 200, 400, and 463 ng/ml correlated with better 1 and 5-year survival rates than levels above 15.1, 200, 400, and 463 ng/ml (P<.05). Conclusions: Elevated preoperative serum alpha-fetoprotein levels have predictive value for hepatocellular carcinoma survival. Resumen: Introducción: Los niveles séricos de alfafetoproteína (AFP) preoperatoria pueden tener valor predictivo para la sobrevida del hepatocarcinoma (HCC). Objetivo: Analizar la correlación entre los niveles séricos de AFP preoperatoria y la sobrevida posterior al tratamiento quirúrgico del HCC. Métodos: Diecinueve pacientes fueron seguidos prospectivamente (julio del 2005-enero del 2016). Se realizó una curva ROC para determinar la sensibilidad y la especificidad de la AFP con relación con la sobrevida (Kaplan-Meier). Resultados: Se evaluó a 19 pacientes, 57.9% hombres, edad media 68.1 ± 8.5 años con sobrevida a 1, 3 y 5 años del 89.4, el 55.9 y el 55.9%. El punto de corte de AFP fue 15.1 ng/ml (sensibilidad 100%, especificidad 99.23%). Los niveles preoperatorios de AFP menores de 15.1, 200, 400 y 463 ng/ml correlacionaron con mejor sobrevida a 1 y 5 años que niveles mayores de AFP (p < 0.05). Conclusiones: Los niveles séricos preoperatorios elevados de AFP tienen valor predictivo en relación con la sobrevida de HCC. Keywords: Hepatocellular carcinoma, Liver resection, Alpha-fetoprotein, Survival, Palabras clave: Hepatocarcinoma, Resección hepática, Alfafetoproteína, Sobrevida |
url |
http://www.sciencedirect.com/science/article/pii/S2255534X17300919 |
work_keys_str_mv |
AT gmartinezmier correlationbetweenpreoperativeserumalphafetoproteinlevelsandsurvivalwithrespecttothesurgicaltreatmentofhepatocellularcarcinomaatatertiarycarehospitalinveracruzmexico AT sesquiveltorres correlationbetweenpreoperativeserumalphafetoproteinlevelsandsurvivalwithrespecttothesurgicaltreatmentofhepatocellularcarcinomaatatertiarycarehospitalinveracruzmexico AT anavalacorte correlationbetweenpreoperativeserumalphafetoproteinlevelsandsurvivalwithrespecttothesurgicaltreatmentofhepatocellularcarcinomaatatertiarycarehospitalinveracruzmexico AT falajudbarquin correlationbetweenpreoperativeserumalphafetoproteinlevelsandsurvivalwithrespecttothesurgicaltreatmentofhepatocellularcarcinomaatatertiarycarehospitalinveracruzmexico AT szillihernandez correlationbetweenpreoperativeserumalphafetoproteinlevelsandsurvivalwithrespecttothesurgicaltreatmentofhepatocellularcarcinomaatatertiarycarehospitalinveracruzmexico AT lmvazquezramirez correlationbetweenpreoperativeserumalphafetoproteinlevelsandsurvivalwithrespecttothesurgicaltreatmentofhepatocellularcarcinomaatatertiarycarehospitalinveracruzmexico |
_version_ |
1725853259839569920 |